G. Kieselbach

Plasma levels of vascular endothelial growth factor before and after intravitreal injection of bevacizumab, ranibizumab and pegaptanib in patients with age-related macular degeneration, and in patients with diabetic macular oedema

Claus Zehetner, Rudolf Kirchmair, Stefan Huber et al. · British Journal of Ophthalmology · 2013 · 160 citations

Medicine, Ophthalmology, Pharmacotherapy +17

Systemic levels of vascular endothelial growth factor before and after intravitreal injection of aflibercept or ranibizumab in patients with age‐related macular degeneration: a randomised, prospective trial

Claus Zehetner, Martina Kralinger, Yasha S. Modi et al. · Acta Ophthalmologica · 2014 · 102 citations

Medicine, Ophthalmology, Pharmacotherapy +16

In vitro human polymorphonuclear leukocyte chemokinesis and human monocyte chemotaxis are different activities of aminoterminal and carboxyterminal substance P

Christian J. Wiedermann, Franz J. Wiedermann, A. Apperl et al. · Naunyn-Schmiedeberg s Archives of Pharmacology · 1989 · 78 citations

Life Sciences, Immunology, Pharmacology +13

Ocular aspirin distribution: a comparison of intravenous, topical, and coulomb-controlled iontophoresis administration.

M. Voigt, Martina Kralinger, G. Kieselbach et al. · PubMed · 2002 · 49 citations

Pharmacy, Pharmacokinetics, Pharmacology +15

Correlation of vascular endothelial growth factor plasma levels and glycemic control in patients with diabetic retinopathy

Claus Zehetner, Rudolf Kirchmair, Martina Kralinger et al. · Acta Ophthalmologica · 2013 · 39 citations

Medicine, Endocrinology, Ophthalmology +14